Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Julio Delgado, Itziar Salaverría, Eriong Lee, Laura Jiménez, Alba Navarro, Dolors Colomer, Ivan Dlouhy, Laura Conde, Alejandra Martinez-Trillos, Cristina Lopez, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, María Rozman, Eva Giné, Dolors Costa, Anna Carrió, Armando López-Guillermo, Elías Campo, Sílvia Beà

Blood (2012) 120 (21): 4577.

https://doi.org/10.1182/blood.V120.21.4577.4577

Published: 2012

Journal Articles

Pattern of Relapse and Progression After Autologous Stem-Cell Transplantation As Upfront Treatment for Multiple Myeloma

Carlos Fernández de Larrea, Raquel Jiménez, Laura Rosiñol, MD, Eva Giné, Natalia Tovar, María Teresa Cibeira, Francesc Fernandez-Avilés, Carmen Martinez, Montserrat Rovira, Joan Blade, MD

Blood (2012) 120 (21): 3987.

https://doi.org/10.1182/blood.V120.21.3987.3987

Published: 2012

Journal Articles

Initial Features and Outcome Are Similar in Patients with Lymphoplasmacytic Lymphoma Regardless They Meet or Not Criteria of Waldenström Macroglobulinemia,

Eva Giné, MD, Jordina Rovira, MD, Alejandra Martinez-Trillos, MD, Neus Villamor, MD. PhD, Antonio Martinez, MD, Gonzalo Gutierrez-Garcia, MD, Luis Colomo, MD, Julio Delgado, MD, Tycho Stephan Baumann, MD, Elias Campo, MD, María Rozman, Armando Lopez-Guillermo, MD

Blood (2011) 118 (21): 3677.

https://doi.org/10.1182/blood.V118.21.3677.3677

Published: 2011

Journal Articles

No Benefit from Rituximab Containing Regimens in Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma

Gonzalo Gutiérrez-García, Luis Colomo, Neus Villamor, Leonor Arenillas, Antonio Martínez, Mireia Camós, Marina Diaz-Beyá, Carlos Fernández de Larrea, Xavier Calvo, Eva Giné, Francesc Bosch, Elias Campo, Emili Montserrat, Armando López-Guillermo

Blood (2008) 112 (11): 3615.

https://doi.org/10.1182/blood.V112.11.3615.3615

Published: 2008

Journal Articles

FMNL-1 (Formin-Like 1) Gene in Chronic Lymphocytic Leukemia (CLL) Is Overexpressed in Young Patients with Adverse Prognostic Factors and Poor Outcome.

Eva Calpe, PhD, Patricia M.B. Favaro, PhD, Marta Crespo, PhD, Maria Joao Baptista, PhD, Ana Muntañola, MD, Eva Giné, MD, Sara Saad, MD, Emili Montserrat, MD, PhD, Francesc Bosch, MD

Blood (2006) 108 (11): 2775.

https://doi.org/10.1182/blood.V108.11.2775.2775

Published: 2006

Journal Articles

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia

Carol Moreno, Neus Villamor, Dolors Colomer, Jordi Esteve, Eva Giné, Ana Muntañola, Elias Campo, Francesc Bosch, Emili Montserrat

Blood (2006) 107 (11): 4563–4569.

https://doi.org/10.1182/blood-2005-09-3634

Published: 2006

Journal Articles

How I treat refractory CLL

Emili Montserrat, Carol Moreno, Jordi Esteve, Alvaro Urbano-Ispizua, Eva Giné, Francesc Bosch

Blood (2006) 107 (4): 1276–1283.

https://doi.org/10.1182/blood-2005-02-0819

Published: 2006

Journal Articles

Preliminary Report of a Phase 1 Study of CMC-544, an Antibody-Targeted Chemotherapy Agent, in Patients with B-Cell Non-Hodgkin’s Lymphoma (NHL).

Anjali Advani, Eva Giné, Christian Gisselbrecht, Ama Rohatiner, Steven Rosen, Mitchell Smith, Joseph Boni, Chantal Lejeune, Hemant Patel

Blood (2005) 106 (11): 230.

https://doi.org/10.1182/blood.V106.11.230.230

Published: 2005

Journal Articles

Polymorphisms in the Promoter Region of the Mcl-1 Gene Are Associated with Ex Vivo Cytotoxicity but Not with Response to Treatment in Advanced Chronic Lymphocytic Leukemia (CLL).

Neus Villamor, Silvia Marce, Francesc Bosch, Anna Ferrer, Patricia Pérez-Galán, Armando López-Guillermo, Eva Giné, Elías Campo, Emili Montserrat, Dolors Colomer

Blood (2005) 106 (11): 4991.

https://doi.org/10.1182/blood.V106.11.4991.4991

Published: 2005

NARROW

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Pattern of Relapse and Progression After Autologous Stem-Cell Transplantation As Upfront Treatment for Multiple Myeloma

Initial Features and Outcome Are Similar in Patients with Lymphoplasmacytic Lymphoma Regardless They Meet or Not Criteria of Waldenström Macroglobulinemia,

No Benefit from Rituximab Containing Regimens in Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma

FMNL-1 (Formin-Like 1) Gene in Chronic Lymphocytic Leukemia (CLL) Is Overexpressed in Young Patients with Adverse Prognostic Factors and Poor Outcome.

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia

How I treat refractory CLL

Preliminary Report of a Phase 1 Study of CMC-544, an Antibody-Targeted Chemotherapy Agent, in Patients with B-Cell Non-Hodgkin’s Lymphoma (NHL).

Polymorphisms in the Promoter Region of the Mcl-1 Gene Are Associated with Ex Vivo Cytotoxicity but Not with Response to Treatment in Advanced Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only